Please upgrade your browser.
Exelixis has completed the rolling submission of its New Drug Application (NDA) for cabozantinib...
“Get on the map!” Bill Bro, CEO of Chicago-based Kidney Cancer Association (KCA), encourages families that are dealing with kidney cancer to join the charity’s newest social network, KidneyCancer.ME.
The reversible posterior leukoencephalopathy syndrome is a clinical/radiological syndrome characterized by headache, seizures, impaired vision, acute hypertension, and typical magnetic resonance imaging findings. There are several reports in the literature that depict its occurrence in cancer patients.
Are the following statements myths or facts about kidney cancer?
The study is the first to provide evidence of an association between blood-borne virus infection and cancer risk in people with opioid dependency, finding an increased risk for 11 cancers. Six cancers, including prostate and breast cancer, showed a reduced risk.
mTORC1 is a validated therapeutic target for renal cell carcinoma (RCC)
Kidney Cancer Connect enables instant collaboration between patients, caregivers, and family members dealing with a loved one's renal cancer.
Renal cell carcinoma is a group of malignancies arising from the epithelium of the renal tubules.
Tasquinimodâs unique mode of action is highly relevant to target multiple malignant diseases beyond prostate cancer.
According to a regulatory filing, clinical trials for the experimental kidney cancer treatment have been halted due to an excess death rate among the drugâs users, sending Abbottâs share price falling 4.7% to $65.78.
|Powered by NeonCRM|